Ioxitalamic Acid
CAS No. 28179-44-4
Ioxitalamic Acid ( Telebrix; Vasobrix; Acidum Joxitalamicum )
Catalog No. M27163 CAS No. 28179-44-4
Ioxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
5MG | 213 | Get Quote |
|
10MG | 304 | Get Quote |
|
25MG | 537 | Get Quote |
|
50MG | 767 | Get Quote |
|
100MG | 1053 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIoxitalamic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionIoxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
-
DescriptionIoxitalamic Acid is a medical contrast medium and enhances the contrast of structures or fluids in the body in medical imaging.
-
SynonymsTelebrix; Vasobrix; Acidum Joxitalamicum
-
PathwayOthers
-
TargetOther Targets
-
RecptorHuman Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number28179-44-4
-
Formula Weight643.9
-
Molecular FormulaC12H11I3N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)Nc1c(I)c(C(O)=O)c(I)c(C(=O)NCCO)c1I
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Citric acid monohydr...
Citric Acid Monohydrate is a tricarboxylic acid found in citrus fruits. Citric acid is used as an excipient in pharmaceutical preparations due to its antioxidant properties. It maintains stability of active ingredients and is used as a preservative.
-
Alisporivir intermed...
Alisporivir intermediate-1 is an intermediate in the synthesis of Alisporivir and is used for the treatment of inflammatory and viral diseases.
-
Zanthobungeanine
Zanthobungeanine has anti-inflammatory activity, it shows moderate NO production inhibitory activity with an IC50 value of 37.26 mg /L.It shows obviously inhibitoryactivity to platelet aggregation caused by platelet-activating factor (PAF). Zanthobungeanine shows the inhibitory action on the development of A549 cell only in high concentration and has no antipersonnel effect on A549 cell.